Cargando…

Retraction statement: Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunity

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864719/ https://www.ncbi.nlm.nih.gov/pubmed/35228872 http://dx.doi.org/10.1002/cti2.1378

Ejemplares similares

Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunity
por: Dougall, William C., et al.
Publicado: (2019)

Statement of Retraction
Publicado: (2017)

Statement of Retraction
Publicado: (2017)

Statement of Retraction
Publicado: (2021)

Statement of Retraction
Publicado: (2012)

Retraction statement
Publicado: (2014)

Statement of Retraction
Publicado: (2020)

Statement of Retraction
Publicado: (2022)

Retraction Statement
Publicado: (2022)

Retracted: The Impact of Atorvastatin on RANKL Expression in Rats during the Retention Stage after Orthodontic Tooth Movement
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Retracted: Metformin Synergizes with PD-L1 Monoclonal Antibody Enhancing Tumor Immune Response in Treating Non-Small Cell Lung Cancer and Its Molecular Mechanism Investigation
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Statement of Retraction: Study on the molecular mechanism of nightshade in the treatment of colon cancer
Publicado: (2023)

Retraction statement: Gut microbiota and COVID‐19: A systematic review
Publicado: (2023)

Retracted: Exploration of the Effect of Icariin on Nude Mice with Lung Cancer Bone Metastasis via the OPG/RANKL/RANK System
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Statement of Retraction: The relationship between hemodialysis mortality and the Chinese medical insurance type
Publicado: (2019)

Retraction Statement: Predictive validity of a medication adherence measure in an outpatient setting
Publicado: (2023)

Retraction statement: Mucormycosisco‐infection in patients with COVID‐19: A systematic review
Publicado: (2023)

Retraction statement: Prenatal and neonatal complications of COVID‐19: A systematic review
Publicado: (2023)

Retraction statement: Evaluating the effects of air disinfectants in decontamination of COVID‐19 aerosols
Publicado: (2023)

A Novel Bispecific Immunotoxin Delivered by Human Bone Marrow-Derived Mesenchymal Stem Cells to Target Blood Vessels and Vasculogenic Mimicry of Malignant Gliomas [Retraction]
Publicado: (2021)

A Novel Bispecific Antibody Targeting PD-L1 and VEGF With Combined Anti-Tumor Activities
por: Cui, Xiaopei, et al.
Publicado: (2021)

Bispecific antibodies targeting dual tumor-associated antigens in cancer therapy
por: Huang, Shuyu, et al.
Publicado: (2020)

Statement of Retraction: Statins significantly repress rotavirus replication through downregulation of cholesterol synthesis
Publicado: (2022)

Retraction Statement: Atypical parkinsonism and self‐mutilation: A new lens on the old concept
Publicado: (2023)

Retraction statement: Virtual clinic in pregnancy and postpartum health care: A systematic review
Publicado: (2023)

Retraction statement: Design, development, and evaluation of a registry system for hyperbaric ‎oxygen therapy
Publicado: (2023)

Retraction statement: COVID‐19 mortality and its predictors in the elderly: A systematic review
Publicado: (2023)

Statement of Retraction: Clinical significance of serum MicroRNA-203 in patients with acute myeloid leukemia
Publicado: (2020)

Statement of Retraction: PSB0788 ameliorates maternal inflammation‐induced periventricular leukomalacia-like injury
Publicado: (2023)

Retraction Statement: Novel NAD‐independent Avibacterium paragallinarum: Isolation, characterization and molecular identification in Iran
Publicado: (2023)

Retraction statement: MicroRNA‐431 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the ZEB1‐mediated epithelial–mesenchymal transition
Publicado: (2022)

Retracted: Allium cepa L. and Quercetin Inhibit RANKL/Porphyromonas gingivalis LPS-Induced Osteoclastogenesis by Downregulating NF-κB Signaling Pathway
por: Evidence-Based Complementary and Alternative Medicine,
Publicado: (2019)

PD-L1/LAG-3 bispecific antibody enhances tumor-specific immunity
por: Jiang, Haiping, et al.
Publicado: (2021)

Retracted: Risk Factors for Thyroid Dysfunction in Patients with Advanced Non-Small-Cell Lung Cancer Treated with PD-1 Antibody
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Retracted: Clinical Study of Anti-PD-1 Immunotherapy Combined with Gemcitabine Chemotherapy in Multiline Treatment of Advanced Pancreatic Cancer
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Retracted: The Application of Targeted Nanodrugs with Dual Responsiveness of PH and Ros in Preventing and Treating Vascular Restenosis
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retraction statement: RGB and HSV quantitative analysis of autofluorescence bronchoscopy used for characterization and identification of bronchopulmonary cancer
Publicado: (2020)

Statement of retraction: [thiophen urea derivatives as a new class of hepatitis C virus entry inhibitors]
Publicado: (2021)

Retracted: Evaluation Analysis of the Nephrotoxicity of Tripterygium wilfordii Preparations with CONSORT Harms Statement Based on Deep Learning
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retracted: Sentiment Analysis of Statements on Social Media and Electronic Media Using Machine and Deep Learning Classifiers
por: Intelligence and Neuroscience, Computational
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fck6476bbie6aasrldbugtlao8